Literature DB >> 23908379

Aryl hydrocarbon receptor control of adaptive immunity.

Francisco J Quintana1, David H Sherr.   

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that belongs to the family of basic helix-loop-helix transcription factors. Although the AhR was initially recognized as the receptor mediating the pathologic effects of dioxins and other pollutants, the activation of AhR by endogenous and environmental factors has important physiologic effects, including the regulation of the immune response. Thus, the AhR provides a molecular pathway through which environmental factors modulate the immune response in health and disease. In this review, we discuss the role of AhR in the regulation of the immune response, the source and chemical nature of AhR ligands, factors controlling production and degradation of AhR ligands, and the potential to target the AhR for therapeutic immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908379      PMCID: PMC3799235          DOI: 10.1124/pr.113.007823

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  154 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.

Authors:  Ada Yeste; Meghan Nadeau; Evan J Burns; Howard L Weiner; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

3.  Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor.

Authors:  Emma Wincent; Johanna Bengtsson; Afshin Mohammadi Bardbori; Tomas Alsberg; Sandra Luecke; Ulf Rannug; Agneta Rannug
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

4.  Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review).

Authors:  Stephen Safe; Andrew McDougal
Journal:  Int J Oncol       Date:  2002-06       Impact factor: 5.650

Review 5.  Infections and autoimmunity--good or bad?

Authors:  Urs Christen; Matthias G von Herrath
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Lesions of aryl-hydrocarbon receptor-deficient mice.

Authors:  P M Fernandez-Salguero; J M Ward; J P Sundberg; F J Gonzalez
Journal:  Vet Pathol       Date:  1997-11       Impact factor: 2.221

7.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.

Authors:  Iain A Murray; Jose L Morales; Colin A Flaveny; Brett C Dinatale; Chris Chiaro; Krishnegowda Gowdahalli; Shantu Amin; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

9.  FICZ, a tryptophan photoproduct, suppresses pulmonary eosinophilia and Th2-type cytokine production in a mouse model of ovalbumin-induced allergic asthma.

Authors:  Kyu-Tae Jeong; Sung-Jun Hwang; Gap-Soo Oh; Joo-Hung Park
Journal:  Int Immunopharmacol       Date:  2012-05-04       Impact factor: 4.932

10.  In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling.

Authors:  Henry Yim Wu; Francisco J Quintana; Andre Pires da Cunha; Benjamin T Dake; Thomas Koeglsperger; Sarah C Starossom; Howard L Weiner
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

View more
  119 in total

1.  Mixed Vehicle Emissions Induces Angiotensin II and Cerebral Microvascular Angiotensin Receptor Expression in C57Bl/6 Mice and Promotes Alterations in Integrity in a Blood-Brain Barrier Coculture Model.

Authors:  Usa Suwannasual; JoAnn Lucero; Griffith Davis; Jacob D McDonald; Amie K Lund
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

2.  Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†.

Authors:  Yan Li; Chi Zhou; Wei Lei; Kai Wang; Jing Zheng
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

Review 3.  Control of immune-mediated pathology via the aryl hydrocarbon receptor.

Authors:  Michael A Wheeler; Veit Rothhammer; Francisco J Quintana
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

4.  LeA(H)Rning self-control.

Authors:  Francisco J Quintana
Journal:  Cell Res       Date:  2014-07-25       Impact factor: 25.617

5.  AhR: far more than an environmental sensor.

Authors:  F Fallarino; L Romani; P Puccetti
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α.

Authors:  Ivan D Mascanfroni; Maisa C Takenaka; Ada Yeste; Bonny Patel; Yan Wu; Jessica E Kenison; Shafiuddin Siddiqui; Alexandre S Basso; Leo E Otterbein; Drew M Pardoll; Fan Pan; Avner Priel; Clary B Clish; Simon C Robson; Francisco J Quintana
Journal:  Nat Med       Date:  2015-05-25       Impact factor: 53.440

Review 7.  Human Health and Ocean Pollution.

Authors:  Philip J Landrigan; John J Stegeman; Lora E Fleming; Denis Allemand; Donald M Anderson; Lorraine C Backer; Françoise Brucker-Davis; Nicolas Chevalier; Lilian Corra; Dorota Czerucka; Marie-Yasmine Dechraoui Bottein; Barbara Demeneix; Michael Depledge; Dimitri D Deheyn; Charles J Dorman; Patrick Fénichel; Samantha Fisher; Françoise Gaill; François Galgani; William H Gaze; Laura Giuliano; Philippe Grandjean; Mark E Hahn; Amro Hamdoun; Philipp Hess; Bret Judson; Amalia Laborde; Jacqueline McGlade; Jenna Mu; Adetoun Mustapha; Maria Neira; Rachel T Noble; Maria Luiza Pedrotti; Christopher Reddy; Joacim Rocklöv; Ursula M Scharler; Hariharan Shanmugam; Gabriella Taghian; Jeroen A J M van de Water; Luigi Vezzulli; Pál Weihe; Ariana Zeka; Hervé Raps; Patrick Rampal
Journal:  Ann Glob Health       Date:  2020-12-03       Impact factor: 2.462

8.  Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Iain A Murray; Seokwon Lee; Haley F Hazlett; Gary H Perdew; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2017-03-20       Impact factor: 4.219

Review 9.  Metabolites: deciphering the molecular language between DCs and their environment.

Authors:  Lucía Minarrieta; Peyman Ghorbani; Tim Sparwasser; Luciana Berod
Journal:  Semin Immunopathol       Date:  2016-12-05       Impact factor: 9.623

Review 10.  Role of AHR and HIF-1α in Glioblastoma Metabolism.

Authors:  Galina Gabriely; Michael A Wheeler; Maisa C Takenaka; Francisco J Quintana
Journal:  Trends Endocrinol Metab       Date:  2017-03-16       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.